Abstract:p53 (TP53) is the most frequently mutated gene in squamous cell carcinomas (SCCs) of the skin and head and neck. Certain p53 mutations are oncogenic and promote invasion and metastasis in SCCs. However, it is unclear how the oncogenic function of mutant p53 is modulated by other molecular alterations that co-exist in SCCs. Here, we show that deletion of the p53 gene and activation of an endogenous This article is protected by copyright. All rights reserved. This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/path.4770 A cc ep te d A rti cl e p53 gain-of-function mutation in the skin induces carcinomas with similar kinetics and penetrance. Deletion of p53 induced primarily well-differentiated SCCs. However, most of the tumours induced by p53 were poorly differentiated SCCs, the only metastatic tumours in this model. These tumours expressed higher levels of Cyclin D1 than the well differentiated SCCs and spindle carcinomas that developed in these mice. Unexpectedly, metastasis was not observed in mice that developed spindle carcinomas, which expressed high levels of the tumour suppressors p16 and p19, encoded by Cdkn2a, a gene frequently deleted in human SCCs. Remarkably, deletion of the Cdkn2a gene in p53-induced SCCs promoted a dramatic increase in metastasis rates and a shorter survival in mice that developed these tumours, compared with those observed in mice with tumours in which Cdkn2a was deleted in the presence of a p53 loss-of-function mutation or wild-type p53. Accordingly, the survival of patients with head and neck SCCs bearing co-occurring high-risk p53 mutations and CDKN2A homozygous deletions was much shorter than that of patients with tumours in which high-risk p53 mutations did not contain CDKN2A homozygous deletions, or that of patients with tumours in which homozygous CDKN2A deletions co-existed with either low-risk p53 mutations or potential loss-of-function mutations in p53. These findings genetically identify a population of SCC patients with worst outcomes and will help predict outcomes according to the p53 status and alterations in CDKN2A.

14‐3‐3σ/Stratifin and p21 limit AKT‐related malignant progression in skin carcinogenesis following MDM2‐associated p53 loss

P57(Kip2) Expression is Related to Carcinogenesis and Tumor Progression in Laryngeal Tissues

Effect of STAT3 phosphorylation and p53 expression on human epidermal non melanoma cutaneous tumors]

Clinical Significance of Stat3 and Mapk Phosphorylation, and the Protein Expression of Cyclin D1 in Skin Squamous Cell Carcinoma Tissues

The Significance of STAT3 and MAPK Phosphorylation and Cyclind1 Protein Expression in Skin Squamous Cell Carcinoma

Expression of a P53 Mutant in the Epidermis of Transgenic Mice Accelerates Chemical Carcinogenesis

Pten Loss Promotes Ras(Ha)-Mediated Papillomatogenesis Via Dual Up-Regulation of Akt Activity and Cell Cycle Deregulation but Malignant Conversion Proceeds Via Pten-Associated Pathways

Cystatin C Deficiency Promotes Epidermal Dysplasia in K14-HPV16 Transgenic Mice.

Epidermal ROCK2 induces AKT1/GSK3β/β-catenin, NFκB and dermal tenascin C; but enhanced differentiation and p53/p21 inhibit papilloma

Mutant Nrf2E79Q enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors

Stratifin in ocular surface squamous neoplasia and its association with p53

Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis.

Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression

Genetic Deletion Of P21(Waf1) Enhances Papilloma Formation But Not Malignant Conversion In Experimental Mouse Skin Carcinogenesis

Deletion of p53 and Hyper-Activation of PIK3CA in Keratin-15+ Stem Cells Lead to the Development of Spontaneous Squamous Cell Carcinoma

Stathmin is Overexpressed and Regulated by Mutant P53 in Oral Squamous Cell Carcinoma.

Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation

Loss of P21 CIP1/WAF1 Does Not Recapitulate Accelerated Malignant Conversion Caused by P53 Loss in Experimental Skin Carcinogenesis

Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis

Mutant p 53 and Cdkn 2 a deletion induce metastatic SCCs

Multifaceted role for p53 in pancreatic cancer suppression